Studies have revealed that patients exhibiting low Ki-67 expression tend to experience prolonged progression-free survival (PFS) and overall survival (OS), whereas upregulation of Ki-67 correlates with heightened PC aggressiveness3,4. This evidence concerns the gene MKI67 and pachyonychia congenita.